Business Context and Reporting Period
This Form 8-K filing by Myomo, Inc. is dated June 12, 2017. The report serves to present unaudited pro forma financial information to the NYSE MKT exchange following the company's initial public offering (IPO) and a concurrent private placement completed on June 9, 2017.
Key Financial Metrics and Capitalization
- Total Proceeds Raised: $7,916,620
- IPO Proceeds: $4,991,235 from the sale of 665,498 shares of common stock at $7.50 per share.
- Private Placement Proceeds: $2,925,385 from the sale of 557,216 investment units at $5.25 per unit.
- Private Placement Structure: Each unit consists of one share of restricted common stock and a 3-year warrant to purchase one share of common stock exercisable at $7.50 per share.
- Operating Metrics: The filing text does not provide specific values for revenue, profit, cash flow, margins, or debt levels.
Material Changes
The primary material change reported is the significant increase in capitalization resulting from the June 9, 2017, capital raise. The filing includes an unaudited pro forma capitalization table for the quarter ended March 31, 2017, giving effect to these transactions as if they had occurred on that date.
Outlook, Risks, and Management Commentary
The filing identifies Myomo, Inc. as an emerging growth company. There is no specific forward-looking guidance, risk factor discussion, or management commentary regarding future operations included in this specific text excerpt, other than the disclosure of the completed capital raise and the attached pro forma capitalization table.
Key Facts for Investor Verification
- Verify the total number of outstanding shares and warrants post-IPO using the attached Exhibit 99.1 (Unaudited pro forma capitalization table).
- Confirm the exercise price and expiration date of the warrants issued in the private placement ($7.50 per share, 3-year term).
- Review the company's audited financial statements for the quarter ended March 31, 2017, to understand the baseline financial position prior to the pro forma adjustments.
- Check the use of proceeds from the $7.9 million raise in subsequent filings or the IPO prospectus.